Monthly Archives: July 2018

Increased Use of Truvada for PrEP Linked to Decline in New HIV Cases

Results from a nationwide analysis on the impact of Truvada for pre-exposure prophylaxis (PrEP) showed that its use resulted in significant declines in new HIV infections in the US from 2012 to 2016. Findings from the study were presented at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam. Using the National HIV Surveillance System and national pharmacy data, researchers from Emory University Rollins School of Public Health and the Centers for Disease Control and Prevention (CDC) found that across the US, the prevalence...

Why Don’t More Americans Use PrEP?

On July 3, 1981, this newspaper wrote about a “rare cancer” killing gay men in New York and California. Though few knew it, what followed would be a generation-defining battle: for attention, for legitimacy, for our very lives. Today, after 37 years, we finally have a proven pathway to ending the AIDS epidemic in this country. The only catch? Poor policy and pharmaceutical price-gouging have blocked the way, making critical drugs a luxury rather than an imperative. The solution comes in a...